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Fluorescein isothiocyanate conjugated human plasma libronectin, 70-kDa collagen-binding, 60-kDa cen- 
tral, 60-kDa heparin-binding, 180-kDa heparin, collagen-binding tibronectin fragments and gelatin were 
used to study extracellular fibronectin matrix formation. Exogenous libronectin, gelatin, 70-kDa col- 
lagen-binding and 180-kDa heparin, collagen-binding fragments were shown to be able to bind specifically 
to preexisting extracellular matrix of living libroblasts. The results suggest hat: (i) Fibronectin matrix for- 
mation may occur through a self-assembly process; (ii) the NH,-terminal part of libronectin is responsible 
for libronectin-fibronectin interaction during libronectin libril formation; (iii) plasma libronectin may be 
the source for tissue tibronectin. 
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1. INTRODUCTION 
The cells of eucaryotic organisms are bathed in 
an environment of extracellular matrices. The im- 
portance of matrices for different basic cellular 
functions is now generally accepted [l]. Fibronec- 
tin is a high molecular mass glycoprotein that is a 
major component of extracellular matrix [2-41. In 
extracellular matrices, besides binding to cell sur- 
face and other matrix components such as collagen 
and proteoglycans, fibronectin molecules associate 
directly to form filaments. Antiserum raised 
against human plasma fibronectin has been used to 
localize fibronectin by immunofluorescence, which 
reveals a 3-dimensional matrix consisting of fine 
fibrils. Cellular fibronectin exists as an insoluble 
tissue protein found in the extracellular matrix and 
on cell surfaces. In a soluble form fibronectin is 
present in human plasma (0.3 mg/ml). The func- 
tion of plasma fibronectin is not yet known. 
Recently, in vivo and in vitro experiments have 
demonstrated that plasma fibronectin can be in- 
* To whom correspondence should be addressed 
Extracellular matrix formation 
corporated into extracellular matrices of different 
tissues and cultured cells [5]. It has been suggested 
that plasma fibronectin may provide a reservoir 
for tissue fibronectin [6]. 
Here, the role of fibronectin-fibronectin interac- 
tions in extracellular matrix formation was in- 
vestigated. We demonstrated that exogenous 
fibronectin, 180-kDa heparin, collagen-binding 
fragment, 70-kDa collagen-binding fragment and 
gelatin were able to bind specifically to ex- 
tracellular matrix of living fibroblasts. Results ob- 
tained suggest that plasma fibronectin may be a 
source for tissue fibronectin and that fibronectin 
matrix formation may occur through a self- 
assembly process on preexisting fibronectin fibrils. 
2. MATERIALS AND METHODS 
Fibronectin was isolated from human plasma by 
gelatinBepharose chromatography [8]. Tryptic 
fragments of M, = 180000 (180-kDa heparin, 
collagen-binding), 70000 (70-kDa collagen- 
binding), 60000 (60-kDa central), 60000 (60-kDa 
heparin-binding) were produced and isolated as 
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described earlier [9]. Fibronectin, its fragments, 
gelatin and IgG at concentrations l-2 mg/ml were 
conjugated to fluorescein isothiocyanate (0.1 mg/ 
ml) in 0.1 M carbonate-bicarbonate buffer (pH 
9.3) at room temperature for 2 h with constant 
stirring. Unreacted dye was removed by gel filtra- 
tion through a Sephadex G-25 column in phos- 
phate-buffered saline (pH 7.4) (PBS). The ratio of 
fluorescein to proteins was 3-4. Fluorescein 
isothiocyanate-conjugated proteins were stored in 
aliquots at -70°C. 
Human skin fibroblasts were grown on glass 
coverslips in Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% fetal calf serum. 
All experiments were performed between passages 
8-10 and 2 days after the cells reached confluence. 
Cells on coverslips were washed twice in DMEM 
and incubated with 0.5 mg/ml FITC-protein in 
DMEM at 37°C for 4 h. The coverslips were 
washed twice in DMEM, fixed with 5% parafor- 
maldehyde for 20 min, rinsed, mounted in 50% 
glycerine-PBS and photographed on a Zeiss 
photomicroscope III equipped with phase contrast 
and epifluorescence. 
Isolated cell matrices were obtained by extract- 
ing confluent cell layers with buffer, containing 
0.025 M Tris-HCl, 0.01 M EGTA, 1% Triton 
X-100 (pH 9.6) for 20 min at 20°C. Cell-free 
matrix was washed in DMEM and incubated with 
fluoresceinated fibronectin. 
3. RESULTS AND DISCUSSION 
We have used fluorescein isothiocyanate (FITC) 
conjugated human plasma fibronectin, fibronectin 
framents - 180-kDa heparin, collagen-binding, 
70-kDa collagen-binding (NHz-terminal third of 
the molecule), 60-kDa central, 60-kDa heparin- 
binding (COOH-terminal third of the molecule) - 
and gelatin to study the incorporation of these pro- 
teins into fibronectin matrices of living human skin 
fibroblasts. Fig.la,e,f,i shows that fluoresceinated 
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Fig. 1. Binding of fluoresceinated exogenous fibronectin, fibronectin fragments and gelatin to cell layers of human skin 
fibroblasts. Fibroblasts were incubated with: (a) FITC-fibronectin; (d) FITC-IgG; (e) FITC-70 kDa collagen-binding 
fragment; (f) FITC-180 kDa heparin, collagen-binding fragment; (g) FITC-60 kDa central fragment; (h) FITC-60 kDa 
heparin-binding fragment; (i) FITC-gelatin. (b) Triton X-100 insoluble fibronectin matrix was incubated with FITC- 
fibronectin. (c) Artificial fibrillar collagen matrix was incubated with FITC-fibronectin. (j) Immunofluorescence 
staining of cell layer of human skin fibroblasts with antibody to fibronectin. 
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fibronectin, 180-kDa heparin, collagen-binding 
fragment, 70-kDa collagen-binding fragment and 
gelatin can bind to confluent cell layers of cultured 
human skin fibroblasts. Fluoresceinated fibronec- 
tin, some fibronectin fragments and gelatin at con- 
centrations of 0.5 mg/ml stain an extensive net- 
work of fibers of fibroblast extracellular matrices. 
This fibrous network consists of fibers of different 
apparent diameters. Fluoresceinated IgG and some 
fibronectin fragments - 60-kDa central and 
60-kDa heparin-binding - practically do not bind 
to cell layers of fibroblasts (fig.ld,g,h). We con- 
sider the binding of fluoresceinated fibronectin 
and 180- and 70-kDa fibronectin fragments to be 
specific for several reasons: (i) the dilution of 
fluoresceinated fibronectin and fragments with 
lo-fold excess of unlabeled fibronectin decreases 
the fluorescence of extracellular matrices (not 
shown); (ii) non-immune immunoglobulin G (IgG) 
does not stain the matrix (fig. Id); (iii) the character 
of staining is typical for ~brone~tin location as 
revealed by staining of extracellular matrices with 
specific antibody to fibronectin and fluores- 
ceinated gelatin (fig.li,j); (iv) fluoresceinated 
fibronectin and fibronectin fragments retain their 
biological activity - binding to heparin and 
gelatin, promoting adhesion of fibroblasts (not 
shown). The fluoresceinated proteins became 
associated with extracellular matrix fibrils even 
after 15-20 min of incubation. Fluoresceinated 
fibronectin can also incorporate into detergent- 
insoluble extracellular matrix prepared by extract- 
ing a confluent fibroblast cell layer with 1% Triton 
X-100 (fig.lb). More than 90% of the proteins in 
this matrix are fibronectin, suggesting that the 
matrix is made of only one component - fibronec- 
tin [lo]. The distribution of fluoresceinated 
fibronectin in isolated fibronectin matrix is similar 
compared with extracellular matrix of non-ex- 
tracted with Triton X-100 fibroblasts. Fluores- 
ceinated fibronectin and 180- and 70-kDa collagen- 
binding fragments also are able to stain the ar- 
tificial fibrillar collagen matrices (fig.lc). In this 
case the character of staining was completely dif- 
ferent from staining of natural fibronectin 
matrices. 
It has been suggested that interactions of 
fibronectin with other matrix components uch as 
collagen and proteoglycans could be important for 
extracellular matrix formation [l l-l 31. The pre- 
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sent findings demonstrate that fibronectin- 
fibronectin interactions are enough for fibronectin 
matrix formation on preexisting fibronectin fibrils. 
It means that formation of extracellular fibronec- 
tin fibrils may occur through a self-assembly pro- 
cess. The NHz-terminal (collagen-binding) part of 
the fibronectin molecule is responsible for fibro- 
nectin-fibronectin interactions during fibronectin 
fibril formation. This conclusion is based on: (i) 
data presented in this paper - the 70-kDa collagen- 
binding fragment was shown to be able to bind 
specifically to fibronectin extracellular matrix; (ii) 
it was found that the gelatin-binding fragment 
could also interact with intact fibronectin, and 
therefore contains a site involved in fibrone~tin- 
fibronectin associations [14]. Fibronectin-fibro- 
nectin binding is suggested by the known ability of 
fibronectin molecules to assemble into filaments in 
vitro [15]. Recently it was shown that plasma 
fibronectin may be incorporated into extracellular 
matrix via specific cell-surface receptors [7,16,173. 
Immunofluorescence studies of fibroblasts treated 
by cytochalasin B suggest that movement of 
receptor-attached fibronectin on the cell surface 
may be involved in fibronectin fibril formation 
[18]. Our observations demonstrate that in addi- 
tion to a cell-dependent mechanism of fibronectin 
fibril formation, exogenous fibronectin becomes 
incorporated into preexisting extracellular matrix 
through a self-assembly process, that may provide 
a mechanism for recruiting plasma fibronectin into 
extracellular matrix. 
The binding of the exogenous 180-kDa heparin, 
collagen-binding fragment to the extracellular 
matrix of fibroblasts seems to be of special in- 
terest. This fragment lacks parts of the NH2 
(27 kDa) and COOH (6 kDa) termini of the 
fibronectin polypeptide chains f 19,201. The 
27-kDa fragment contains the site at which 
fibronectin is cross-linked to fibrin and collagen by 
blood coagulation Factor XIII [21]. The 6-kDa 
fragment contains interchain disulfide bonds [20]. 
Therefore, the 180-kDa heparin, collagen-binding 
fragment is a monomer and lacks the ability to be 
covalently cross-linked to fibrin and collagen. In 
contrast to intact fibronectin, the 180-kDa 
heparin, collagen-binding fragment has an unfold- 
ed conformation in solution [22]. Nevertheless, 
this fragment may bind to extracellular matrix. It 
means that the NHz-terminated 27-kDa part of the 
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fibronectin molecule, COOH-terminal interchain 
disulfide bonds and compact conformation are not 
necessary for incorporation of fibronectin into the 
extracellular matrix. 
REFERENCES 
[l] Hay, E.D. (1981) Cell Biology of Extracellular 
Matrix, Plenum Press, New York. 
[2] Ruoslahti, E., Engvall, E. and Hayman, E.G. 
(1981) COIL Res. 1, 95-128. 
131 Hynes, R.O. and Yamada, K.M. (1982) J. Cell 
Biol. 95, 369-377. 
[4] Yamada, K.M. (1983) Ann. Rev. Biochem. 52, 
761-799. 
[5] Hayman, E.G. and Ruoslahti, E. (1979) J. Cell 
Biol. 88, 352-357. 
[6] Oh, E., Pierschbacher, M. and Ruoslahti, E. (1981) 
Proc. Natl. Acad. Sci. USA 78, 3218-3221. 
[7] McKeown-Longo, P.J. and Mosher, D.F. (1983) J. 
Cell Biol. 97, 466-472. 
[8] Engvall, E. and Ruoslahti, E. (1977) Int. J. Cancer 
20, l-5. 
[9] Venyaminov, S.Y., Metsis, M.L., Chernousov, 
M.A. and Koteliansky, V.E. (1983) Eur. J. Bio- 
them. 135, 485-489. 
[lo] Chen, L.B., Murray, A., Segal, R.A., Buchnell, A. 
and Walsh, M.L. (1978) Cell 14, 377-391. 
[ll] McDonald, J.A., Kelley, D.G. and Brockelmann, 
T.J. (1982) J. Cell Biol. 92, 485-492. 
1121 Perkins, M.E., Tae, H.J. and Hynes, R.O. (1979) 
Cell 16, 941-952. 
1131 Rennard, S.I., Wind, M.L., Hewitt, A.T. and 
Kleinman, H.K. (1981) Arch. Biochem. Biophys. 
206, 205-212. 
[14] Ehrisman, R., Roth, D.E., Eppenberger, H.M. and 
Turner, D.C. (1982) J. Biol. Chem. 257, 
7381-7387. 
[15] Vuento, M., Vartio, T., Saraste, M., Von 
Bensdorff, C.H. and Vaheri, A. (1980) Eur. J. Bio- 
them. 105, 33-42. 
[16] Grinnell, F. (1980) J. Cell Biol. 86, 104-112. 
[17] Pena, S.D.J. and Hughes, R.C. (1978) Nature 276, 
80-83. 
[18] Lyubimov, A.V. and Vasiliev, J.M. (1982) Cell 
Biol. Int. Rep. 6, 105-112. 
[19] Ruoslahti, E., Hayman, E.G., Engvall, E., Cotran, 
W.C. and Bulter, W.T. (1981) J. Biol. Chem. 256, 
7277-728 1. 
I201 Petersen, T.E., Thogersen, H.C., Skorstengaard, 
K., Vibe-Pedersen, K., Sahl, P., Sottrup-Jensen, L. 
and Magnusson, S. (1983) Proc. Natl. Acad. Sci. 
USA 80, 137-141. 
1211 Mosher, D.F., Schad, P.E. and Vann, J.M. (1980) 
J. Biol. Chem. 255, 1181-1188. 
[22] Metsis, M.L., Sepetov, N.F., Morozkin, A.D. and 
Koteliansky, V.E. (1985) Biochim. Biophys. Acta, 
in press. 
369 
